VALNEVA SE - ADR (VALN:NASDAQ)
$5.78 0.09 (1.5817%)
Analysed VALNEVA SE - ADR (VALN:NASDAQ) News Sources
Valneva SE (INRLF) (H1 2026) Earnings Call Highlights: Strategic Pivot and Lyme Vaccine ...
13-08-2026
yahoo.com
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
14-08-2026
yahoo.com
Valneva (VALN) Q2 2026 Earnings Call Transcript
20-08-2026
fool.com
Declaration of shares and voting rights - Status as of August 31, 2026
04-09-2026
yahoo.com
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
07-09-2026
yahoo.com
Declaration of shares and voting rights - Status as of September 30, 2026
05-10-2026
yahoo.com
Valneva Provides Update on IXCHIQ® in the United Kingdom
07-10-2026
yahoo.com
Valneva ADRs fall as UK revokes IXCHIQ marketing authorization
07-10-2026
yahoo.com
VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback
07-10-2026
stocktwits.com
Valneva Shares Fall as UK Withdraws Approval for Ixchiq Chikungunya Vaccine
08-10-2026
advfn.com
What is the current price of VALNEVA SE - ADR (VALN:NASDAQ)?
The current price of VALNEVA SE - ADR (VALN:NASDAQ) is $5.78.
VALNEVA SE - ADR (VALN:NASDAQ) absolute price change since previous trading day?
The absolute price change of VALNEVA SE - ADR (VALN:NASDAQ) since the previous trading day is $0.09.
VALNEVA SE - ADR (VALN:NASDAQ) percentage price change since previous trading day?
The percentage price change of VALNEVA SE - ADR (VALN:NASDAQ) since the previous trading day is 1.5817%.
What is the most recent average sentiment score for VALNEVA SE - ADR (VALN:NASDAQ)?
The most recent average sentiment score for VALNEVA SE - ADR (VALN:NASDAQ) is 39 out of 100.
What is the most recent average sentiment for VALNEVA SE - ADR (VALN:NASDAQ)?
The most recent sentiment for VALNEVA SE - ADR (VALN:NASDAQ) is .
SEC-8K** Filing Available For VALNEVA SE - ADR (VALN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.